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Conceptual diagram which illustrates structural stabilization of a polypeptide in
the presence of an external molecule. The biologically active form requires interaction
with a scaffold e a cellular membrane, another protein or a suitable compound.
The structure of the Ab(1e42) amyloid has been compared with its non-
amyloid form, with particular focus on fragments identified as amyloid seeds.
The presented results enable us to identify conformational changes involved
in the amyloid transformation process.
Ever since the discovery of prions, the structure of amyloid aggregations
and the mechanisms by which they emerge have puzzled molecular biolo-
gists [1,2].
Radical conformational rearrangements in the absence of mutations
appear to contradict the prevalent view that the protein’s 3D structure is
fully encoded in the composition of its chain [3].
Particular attention has been accorded to proteins in which conforma-
tional rearrangements produce structures capable of unrestricted growth,
resulting in fibrillar complexes [4]. This phenomenon is of great importance
in biological research since amyloid fibrils cause a variety of pathological
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conditions in living organisms [5]. In particular, they may accumulate in
brain tissue, leading to neurodegeneration [6].
The insolubility of amyloids greatly hampers analysis of their structural
properties. In order to overcome these obstacles prior to invention of
solid-state NMR [7] amyloidogenic peptides were complexed with other
molecules, including other proteins, in order to ensure solubility [8e11].
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